rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2003-9-25
|
pubmed:abstractText |
Estrogen is one of the crucial hormones participating in the proliferation and carcinogenesis of the prostate glands. Genetic polymorphisms in the estrogen metabolism pathway might be involved in the risk of prostate carcinoma development. The authors evaluated the association between genetic polymorphisms in estrogen-related enzymes and receptors and the risk of developing familial prostate carcinoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0008-543X
|
pubmed:author |
pubmed-author:ItoKazutoK,
pubmed-author:KashiwagiBunzoB,
pubmed-author:KoikeHidekazuH,
pubmed-author:MatsuiHiroshiH,
pubmed-author:NakataSeijiS,
pubmed-author:NakazatoHarukiH,
pubmed-author:NishiiMasahiroM,
pubmed-author:OhtakeNobuakiN,
pubmed-author:OkugiHironobuH,
pubmed-author:SuzukiKazuhiroK,
pubmed-author:YamanakaHidetoshiH
|
pubmed:copyrightInfo |
Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11639
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
98
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1411-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14508827-Adult,
pubmed-meshheading:14508827-Age Distribution,
pubmed-meshheading:14508827-Aged,
pubmed-meshheading:14508827-Aromatase,
pubmed-meshheading:14508827-Carcinoma,
pubmed-meshheading:14508827-Case-Control Studies,
pubmed-meshheading:14508827-Catechol O-Methyltransferase,
pubmed-meshheading:14508827-Chi-Square Distribution,
pubmed-meshheading:14508827-Cohort Studies,
pubmed-meshheading:14508827-Estrogen Receptor alpha,
pubmed-meshheading:14508827-Genetic Predisposition to Disease,
pubmed-meshheading:14508827-Humans,
pubmed-meshheading:14508827-Incidence,
pubmed-meshheading:14508827-Japan,
pubmed-meshheading:14508827-Male,
pubmed-meshheading:14508827-Middle Aged,
pubmed-meshheading:14508827-Neoplasm Staging,
pubmed-meshheading:14508827-Odds Ratio,
pubmed-meshheading:14508827-Polymorphism, Genetic,
pubmed-meshheading:14508827-Probability,
pubmed-meshheading:14508827-Prostatic Neoplasms,
pubmed-meshheading:14508827-Receptors, Estrogen,
pubmed-meshheading:14508827-Risk Assessment
|
pubmed:year |
2003
|
pubmed:articleTitle |
Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
|
pubmed:affiliation |
Department of Urology, Gunma University School of Medicine, Maebashi, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|